“Big Data and Black-Box Medical Algorithms”
Nicholson Price- AI, Law, and Technology
- Health Law
Science Translational Medicine
2018
“Drug Approval in a Learning Health System”
Nicholson Price- AI, Law, and Technology
- Health Law
Minnesota Law Review
2018
“Risk and Resilience in Health Data Infrastructure”
Nicholson Price- AI, Law, and Technology
- Health Law
Colorado Technology Law Journal
2017
“Regulating Black-Box Medicine”
Nicholson Price- AI, Law, and Technology
- Health Law
Michigan Law Review
2017
“Artificial Intelligence in Health Care: Applications and Legal Issues”
Nicholson Price- AI, Law, and Technology
- Health Law
The SciTech. Lawyer
2017
“Expired Patents, Trade Secrets, and Stymied Competition”
Nicholson Price- AI, Law, and Technology
- Health Law
Notre Dame Law Review
2017
“Manufacturing Barriers to Biologics Competition and Innovation”
Nicholson Price- AI, Law, and Technology
- Health Law
Iowa Law Review
2016
“Privacy and Accountability in Black-Box Medicine”
Nicholson Price- AI, Law, and Technology
- Health Law
Michigan Telecommunications and Technology Law Review
2016
“Big Data, Patents, and the Future of Medicine”
Nicholson Price- AI, Law, and Technology
- Health Law
Cardozo Law Review
2016
Washington Law Review
2016
“Codon Influence on Large-Scale Protein Expression Correlates with E. coli mRNA Levels”
Nicholson Price- AI, Law, and Technology
- Health Law
Nature
2016
“The Need for a Privacy Standard for Medical Devices That Transmit Protected Health Information Used in the Precision Medicine Initiative for Diabetes and Other Diseases”
Nicholson Price- AI, Law, and Technology
- Health Law
Journal of Diabetes Science and Technology
2016
“Describing Black-Box Medicine”
Nicholson Price- AI, Law, and Technology
- Health Law
Boston University Journal of Science & Technology Law
2015
Harvard Journal of Law & Technology
2015
“Innovation Policy Failures in the Manufacturing of Drugs”
Nicholson Price- AI, Law, and Technology
- Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015
“Introduction to ‘Timing is Everything: Balancing Access and Uncertainty’ ”
Nicholson Price- AI, Law, and Technology
- Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015
Science
2015
“Will Clinical Trial Data Disclosure Reduce Incentives to Develop New Uses of Drugs?”
Nicholson Price- AI, Law, and Technology
- Health Law
Nature Biotechnology
2015
“Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing”
Nicholson Price- AI, Law, and Technology
- Health Law
Boston College Law Review
2014
“Patent Trolling - Why Bio & Pharmaceuticals Are at Risk”
Nicholson Price- AI, Law, and Technology
- Health Law
Stanford Technology Law Review
2014
“Models of Consent to Return of Incidental Findings in Genomic Research”
Nicholson Price- AI, Law, and Technology
- Health Law
Hastings Center Report
2014
“Generic Entry Jujitsu: Innovation and Quality in Drug Manufacturing”
Nicholson Price- AI, Law, and Technology
- Health Law
IP Theory
2014
The American Interest
2014
“Informed Consent for Return of Incidental Findings in Genomic Research”
Nicholson Price- AI, Law, and Technology
- Health Law
Genetics in Medicine
2013
“Problems of Innovation-Deficient Pharmaceutical Manufacturing”
Nicholson Price- AI, Law, and Technology
- Health Law
New England Journal of Medicine
2013
“Unblocked Future: Why Gene Patents Won’t Hinder Whole-Genome Sequencing and Personalized Medicine”
Nicholson Price- AI, Law, and Technology
- Health Law
Cardozo Law Review
2012
“Large-Scale Experimental Studies Show Unexpected Amino Acid Effects on Protein Expression and Solubility in Vivo in E. coli”
Nicholson Price- AI, Law, and Technology
- Health Law
Microbial Informatics and Experimentation
2011
“Am I My Son? Human Clones and the Modern Family”
Nicholson Price- AI, Law, and Technology
- Health Law
Columbia Science and Technology Law Review
2010
“The Deepwater Horizon Oil Spill: Potential Insurance Coverage Implications”
Nicholson Price- AI, Law, and Technology
- Health Law
Insurance Coverage Law Bulletin
2010
“Understanding the Physical Properties that Control Protein Crystallization by Analysis of Large-Sale Experimental Data”
Nicholson Price- AI, Law, and Technology
- Health Law
Nature Biotechnology
2009
“MxA Gene Expression Analysis as an Interferon-beta Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity”
Nicholson Price- AI, Law, and Technology
- Health Law
Molecular Diagnosis
2003
“An Incidental Standard for Medical AI”
Nicholson Price- AI, Law, and Technology
Journal of Law and Innovation